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1. Introduction 
The drug nafoxidine (U. 11,100) behaves in vivo 
as an anti-estrogen aswell as a slight estrogenic com- 
pound on the rat uterus [1-3] .  Its mechanism of 
action is unknown although it was suggested that 
it could act by competing with estradiol for binding 
to its receptor(s) in the target organ [4]. This as- 
sumption was based on the fact that nafoxidine in- 
hibits 3H-estradiol uptake by uterus both in vivo 
[2] and in vitro [4]. The complexity of the system 
makes the results difficult to interpret in molecular 
terms, since this drug could act on the cytosol as 
well as on the nuclear estradiol receptor [5] and/or 
modify estradiol transport through cellular or nuclear 
membranes. 
The purpose of this work is to define more pre- 
cisely the binding characteristics of nafoxidine to 
the estradiol receptor of uterine cytosol. Our results 
show that nafoxidine is a competitive, reversible 
and eventually complete inhibitor of estradiol bind- 
ing to the cytosol receptor in its dissociated and 
non-dissociated form. The affinity for the cytosol 
receptor is about 30 times less than that of estradiol 
(K i ~ 7 nM). 
2. Methods 
(6-7)aH-estradiol was obtained from CEA (speci- 
fic activity = 48 Ci/nM). Nafoxidine (fig. 1) (U. 
11,100:1 -(2-(P-(3,4-dihydro-6-methoxy-2-phenyl- 1- 
naphthyl) phenoxy)-ethyl) pyrrolidine hydrochloride) 
was a gift of Dr. O. Kadruka, research laboratories 
of the Upjohn Company. Non-radioactive estradiol 
was from Roussel. Calf uteri were collected on dry 
ice and homogenized in I0 mM Tris HC1 pH 7.4-1.5 
mM EDTA buffer and the 105,000 g supernatant 
(cytosol) prepared as described previously [6]. 
Similar results were obtained using prepubertal 
rat or calf uteri. The cytosol containing 2 mg pro- 
tein/ml was incubated with ligand at 0 -2  ° for 90 
min, a time long enough to reach binding equilibrium. 
The specific binding of 3H-estradiol to the receptor 
was assayed by adsorption of the unbound ligand 
on dextran-coated charcoal [7]. The cytosol was 
shaken overnight at 0 -2  ° with a suspension of 
Dextran 0.05% and charcoal 0.5% in Tris-EDTA 
b6ffer. At the end of this incubation, the loosely 
bound aH-estradiol, dissociated from non-specific 
protein(s) and adsorbed onto the charcoal, was spun 
down by a 10 min centrifugation at700 g. Aliquots 
of the supernatant were then assayed for specifically 
bound estradiol (Bs) by counting in a toluene scin- 
tillation mixture in the presence of ethanol with 
CH3 .OH 
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Fig. 2. Reversibility:hot chase xperiments. Percentage of
estradiol binding sites (% 3HE2B) are shown before or after 
chase xperiments. In both cases, 3 lots of uterine cytosol 
were incubated at 0 ° for 60 min with the inhibitor (I = 100 
nM), non-radioactive estradiol (E 2 = 10 nM) or without 
ligand, a) Before chase: Half of each lot was subsequently 
incubated with 5 nM 3H-estradiol for 60 min at 0 °, and the 
specific estradiol binding sites were measured by charcoal 
adsorption (see Methods). [3: Control bound 3H-estradiol 
in the absence of inhibitor taken as 100% (= 0.2 pmoles/mg 
protein). []: % 3H-estradiol bound in the presence of inhi- 
bitor. B: % 3H.estradiol bound in the presence of non- 
radioactive estradiol, b) Chase by 3H-estradiol: The other 
half were treated with a dextran-coated charcoal suspension 
at 0 ° for 20 min in order to adsorb unbound ligand. The 
mixtures were then centrifuged and the supernatants in-
cubated with 5 nM 3H-estradiol for 60 min at 0 ° and then 
treated successively at25 ° for 25 min and at 0 ° for 60 min. 
The estradiol binding sites were tested by charcoal adsorp- 
tion (see Methods). [3: Control without inhibitor taken 
as 100% (= 0.1 pmoles/mg protein). The 50% inactivation 
was due to the 25 ° treatment. W: % of 3H-estradiol binding 
sites freed from inhibitor (I). ~: % of 3H-estradiol binding 
sites freed from non-radioactive estradiol (E2). 
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Fig. 3. Reversibility:time course xperiments. Uterine cytosol 
was incubated at 0-2  ° , with 2 nM %t-estradiol in the pres- 
ence (e) or absence (X) of 20 nM nafoxidine. Aliquots were 
withdrawn at different times and assayed for specifically 
bound 3H-estradiol as described under Methods. 
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Fig. 4. Competitive inhibition. Three lots of uterine cytosol 
were incubated for 90 min at 0 ° with increasing concentra- 
tions of 3H-estradiol (X). In 2 of these lots the inhibitor 
(I = 10 nM (o) and I = 50 nM (e)) had been simultaneously 
added with the radioactive ligand. At the end of incubation, 
specifically bound 3 H-estradiol was measured as described 
under Methods. a) Direct plot of bound (E2B) versus un- 
bound (E 2 U) 3H-estradiol, calculated as indicated under 
Methods. b) Double reciprocal plot according to Lineweaver- 
Burk [9]. The 2 plots are from 2 different cytosols. 
30% efficiency. In order to determine the concen- 
tration of  unbound estradiol at equil ibrium (U), 
the non-specif ic binding of  estradiol (Bns) was mea- 
sured by equil ibrium dialysis at 0 -2  ° with aH-estra- 
diol di luted with high concentrat ion of non-radio- 
active estradiol (1 -10/aM) .  The concentrat ion of
unbound estradiol was calculated according to 
U = (T-Bs)/(1 + P) where P is a part it ion coeff icient 
(P = Bns/(U)) [8] determined for each experiment.  
P was found to range between 0 .5 -2  with different 
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Fig. 5. Measurement ofK i :Hunter and Downs plot [10]. 
Five different competition experiments were carried out as 
described under fig. 4. Results were expressed according to 
the equation of Hunter and Downs: 
e Ki 
( I )×~ =K i+Kd X (U) wherec~= 
inhibited binding of estradiol 
uninhibited binding of estradiol " 
Intersection of the linear egression with the vertical axis 
gives the apparent dissociation constant of nafoxidine 
(K i ~ 7 nM). The slope of the linear egression (Ki/K d = 
30 +- 10) indicates the relative affinity of the inhibitor as 
compared to that of estradiol. 
cytosol and was not modified by the presence of 
nafoxidine. 
The purity of estradiol and nafoxidine was check- 
ed by thin layer chromatography on Silica gel F 254 
Merck using, respectively, benzene-ethyl acetate 
(3:2, v/v) and butanol-acetic acid-water (60:20:20, 
v/v/v). No metabolism or alteration of these com- 
pounds was observed after incubation with cytosol. 
3. Results 
3.1. Reversible inhibition 
In order to discriminate between reversible and 
irreversible inhibition, 2 series of experiments were 
carried out: in the first series of experiments (hot 
chase) we determined the amount of estradiol bind- 
ing sites initially occupied by the inhibitor and the 
fraction of those which were liberated through dis- 
sociation of the complex. The detailed experimental 
set up is given under fig. 2a. Under these conditions, 
75% of the sites were occupied by inhibitor before 
dissociation (fig. 2a). During the thermal dissociation 
step about half of binding sites became available for 
aH-estradiol (fig. 2b). This indicates that inhibitor 
binding to receptor is reversible. A complete chase 
could be obtained using longer incubation time or 
higher temperature (45°), but under these condi- 
tions, thermo inactivation of receptor was very im- 
portant. When non-radioactive estradiol was used 
instead of inhibitor, only 15% of the binding sites 
occupied by estradiol were liberated, suggesting that 
estradiol dissociated more slowly than the inhibitor. 
The second type of experiments (time course), 
performed in the presence of both inhibitor and 
3H-estradiol, confirmed that nafoxidine was revers- 
ibly bound since inhibition did not increase with 
time (fig. 3). 
3.2. Competitive inhibition 
Saturation curves were made at different inhi- 
bitor concentrations and plotted on direct and 
double reciprocal coordinates, in order to decide 
whether this inhibitory effect reflects a change in 
the affinity, or in the number of estradiol binding 
sites. In the absence of inhibitor a saturation plateau 
was reached at 2 nM 3H-estradiol, and no non-speci- 
fic binding was detected up to 8 nM (fig. 4a). The 
number of specific binding sites* varied from 
0.1-0.5 pmoles/mg protein according to prepara- 
tion. Fig. 4 shows a typical pattern of competitive 
inhibition on direct and double reciprocal plots [9]. 
The apparent dissociation constant of the inhibitor 
obtained according to a Hunter and Downs plot 
(fig. 5) [10] was K i = 7 nM. Assuming a dissociation 
constant of estradiol in the absence of inhibitor of 
0.2 nM, K i was found to vary between 4 -8  nM from 
the slope of the linear regression. 
3.3. Total inhibition 
When the cytosol was incubated with a constant 
* Expressed in equivalents of bound a H-estradiol. 
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Fig. 6, Complete inhibition. Uterine cytosol made in Tris 
buffer (e) was incubated, for 90 min at 0 °, simultaneously 
with 3H-estradiol (2 nM) and increasing concentrations of 
inhibitor (I). The specifically bound estradiol (E2B) was 
then tested as described under Methods. Similar blank val- 
ues (Blk) were obtained using non-radioactive estradiol 
( 10 ~M) as an ideal competitor or Tris buffer instead of 
cytosol. Similar experiments were carried out in the pres- 
ence of 0.5 M KC1 (o). 
At high concentration, afoxidine has an anti- 
estrogenic activity since it is both a partial agonist 
in vivo on uterine wet weight [11 ] and a complete 
inhibitor of estradiol binding to its receptor in vitro, 
as shown in this paper. Several hypotheses can ac- 
count for the difference in estrogenic action in vivo 
between estradiol and nafoxidine: they could be 
carried differently in blood since estradiol, but not 
nafoxidine, binds to specific plasma protein [12]. 
Another possibility is that the U. 11,100 compound 
would inhibit estrogen action in target cells at other 
site(s) than estradiol receptor(s). However, the sim- 
plest hypothesis i that the interaction of the inhi- 
bitor with the cytosol receptor is less efficient han 
estradiol in inducing the first molecular events 
leading to uterus hypertrophy. This inefficiency can 
be due to the low affinity for the receptor (about 
1/30 that of estradiol) and particularly to its rapid 
dissociation rate and/or to a deficient ransfer of 
the cytosol receptor to the nucleus. This last pos- 
sibility is under study. 
amount of 3H-estradiol and increasing concentrations 
of inhibitor, complete inhibition of estradiol bind- 
ing was obtained with 5#M of inhibitor (fig. 6) in- 
dicating that the cytosol receptor could not simul- 
taneously bind estradiol and nafoxidine. In the pres- 
ence of 0.5 M KC1, which dissociates the cytosol 
receptor into subunits [6], similar inhibition was 
observed. These findings support he existence of a 
common binding site for oestradiol and nafoxidine. 
4. Discussion 
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The presented results show that nafoxidine in- 
hibits estradiol binding to its receptor decreasing 
the affinity without changing the number of sites. 
In addition, the inhibition is fully competitive 
suggesting that nafoxidine binds to the same site as 
estradiol. However, the existence of 2 different 
sites for estradiol and the inhibitor cannot be ruled 
out. In this case, the complete inhibition observed 
would imply that binding of the inhibitor to its 
site drastically decreases the affinity of estradiol 
for its own. On the grounds that the inhibitory 
effect of nafoxidine survives the dissociation of the 
binding protein by KC1, we conclude that inhibitor 
and estradiol bind to same protein subunit. 
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